OncoNote: Enabling the Discovery of a Novel Digital Biomarker for Early Pan-Cancer Survival and Recurrence Prediction via Free-Text Clinical Narratives
ISEF · 2025 Translational Medical Science
Overview
Cancer is the second leading cause of death worldwide, affecting 20 million people and being responsible for >9.7 million deaths annually. Early prediction of clinical outcomes is crucial for patient risk stratification and treatment management, yet current staging systems fail to stratify across cancers, with concordances as low as 52%. Thus, my project presents OncoNote: the first low-cost, non-invasive computational framework to predict the survival and recurrence rates of pan-cancer patients at initial diagnosis using unstructured free-text clinical narratives. First, I train an unsupervised FastText model to process the ~2.3 million clinical narratives from 56,339 patients by removing noise, segmenting sentences, and synthesizing clinical terminology. By learning robust, medically relevant word representations across 686 institutions, the model generates a dataset of document-level embeddings, which is used to train a Cox Proportional Hazards neural network. The model adaptively evaluates prognostically relevant clinical text and predicts a risk score for each patient. After extensive experimentation, the survival and recurrence prediction models achieved impressive concordances of 0.72 and 0.77 across 32 cancer types, surpassing all existing clinical techniques. OncoNote offers clinicians the first pan-cancer, text-based digital biomarker that can be generalized to any electronic health record and will lead to better clinical outcomes by sparing patients from overaggressive therapies. Ultimately, this platform is a scalable, affordable, and comprehensive solution that will enable clinicians to determine robust, targeted treatment plans earlier, prevent adverse clinical events from occurring in the first place, and save millions of lives.
Competition history
- ISEF 2025
Resources
Related projects
ISEF · 2023
BioRx: An Integrative NLP Approach to Early Survival and Recurrence Prediction and Novel Biomarker Discovery in Unstructured Text-Based Clinical Narratives for Diabetes Patients
ISEF · 2022
Novel Prediction of Five-Year Survival and Recurrence Rates and Discovery of Cancer Genetic Biomarkers Using MIBI Scans in the Tumor-Immune Microenvironment
ISEF · 2020
Weakly Supervised LSTM RNNs for Longitudinal Breast Cancer Recurrence Prediction via Unstructured Clinical Narratives
ISEF · 2024
Enabling Scalable Precision Medicine With STAD: A Novel Computational Platform for Early Recurrence-Free Survival Prediction and Biomarker Discovery in Digital Pathology for Gastrointestinal Cancer Patients
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair